Plasmid DNA Manufacturing Market Market - Top Companies and Manufacturers

  • Report ID: 6369
  • Published Date: Aug 30, 2024
  • Report Format: PDF, PPT

Companies dominating the Plasmid DNA Manufacturing Landscape

    The plasmid DNA manufacturing market has a strong competitive landscape globally with a dynamic and diverse eco-system comprising well-established players such as GenScript ProBio, Samsung Biologics, and emerging players, including WuXi Biologics, Fujifilm Diosynth Biotechnologies, and Hanmi Fine Chemical. The National Institute of Advanced Industrial Science and Technology and A*STAR Bioprocessing Technology are two research institutes that are substantially contributing to the advancements within the market. Start-ups, such as GeneTech and PlasmidFactory, are introducing novel solutions to the market.

    Furthermore, the market is enhanced by the regional presence of global businesses, including Lonza and Thermo Fisher Scientific. The plasmid DNA manufacturing market is growing and innovation in this eco-system, is propelled by partnerships, rise in the focus on regenerative medicine, and investments in advanced technologies.

    Some of the major players are:

    • VGXI, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • JAFRAL Ltd.
    • Luminous Biosciences
    • Delphi Genetics
    • Akron Biotech
    • Plasmidfactory GmbH
    • Cobra Biologics & Pharmaceutical Services
    • Vigene Biosciences
    • Aldevron
    • Nature Technology Corporation

Browse Key Market Insights with Data Illustration:

In the News

  • In March 2024, Novel Bio, a leader in biomanufacturing technologies in plasmid DNA, and Culture Biosciences, a digital biomanufacturing company, announced an agreement to develop plasmid DNA. Through this agreement, Novel Bio will assist Culture Biosciences to fasten its development processes for scalable fermentation processes.
  • In June 2023, INADcure Foundation signed an agreement with Charles River Laboratories for phase I/II clinical studies of gene therapy targeting infantile neuroaxonal dystrophy to produce high-quality pDNA.

Author Credits:  Radhika Pawar


  • Report ID: 6369
  • Published Date: Aug 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The plasmid DNA manufacturing market size was USD 1.9 billion in 2023.

The global plasmid DNA manufacturing market size was USD 1.9 billion in 2023 and is anticipated to reach USD 15 billion by the end of 2036, expanding at a CAGR of 18.8% over the forecast period, i.e., 2024-2036.

JAFRAL, Ltd., Delphi Genetics, Aldevron, VGXI, Inc., and Akron Biotech are some prominent companies in the plasmid DNA manufacturing market.

Viral vectors segment is anticipated to hold the largest share.

North America is projected to offer lucrative prospects in the plasmid DNA manufacturing market.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample